The training program provides multidisciplinary predoctoral training in the pharmacological sciences with an emphasis on applying the techniques of basic research to clinically relevant problems. This program is unique at Cornell University (Ithaca) in that it provides a mechanism for students in a number of basic science departments to exchange ideas and techniques with a diverse faculty with a common interest in biophysical and biochemical pharmacology. This program differs from other federally funded institutional training grants at Cornell in that the program exposes students to a variety of disciplines relevant to the pharmacological sciences. The faculty consists of members of the Department of Molecular Medicine (R. Cerione, R. Collins, J. L. Guan, L. Nowak, R. Oswald, B. Pauli, G. Sharp, and N. Winand) as well as members of several other units on the Cornell campus (Department of Chemistry - B. Baird; Department of Molecular Biology and Genetics - G. Hess; School of Applied and Engineering Physics - W. Webb, M. Lindau). The facilities include modem, fully equipped laboratories in the new Veterinary Medical Center, the Biotechnology Building, Olin Chemistry Laboratories, and the School of Applied and Engineering Physics. A number of major collaborations between the faculty are currently ongoing and continue to develop as a result of this program. Geoffrey W.G. Sharp (past Chairman of the Department of Pharmacology) is the program director. Support for six trainees is requested for the five years of the grant. In addition to the Field of Pharmacology, students can apply to nine other graduate fields at Cornell (Applied Physics; Chemistry; Biochemistry, Molecular and Cell Biology; Biophysics; Immunology; Neurobiology and Behavior; Physiology; Comparative Biomedical Sciences; Environmental Toxicology) and minor in pharmacology. Students must meet the requirements of the respective fields and are selected to participate in the Pharmacology Training Program by vote of the participating faculty. The major factors for admission into the program are academic achievement, research promise, and an interest in pursuing a career in the pharmacological sciences. The pool of students from which to select our trainees is uniformly excellent. Outstanding students are available to participate in this program and the program meets a very real need of teaching both modem techniques in the biological and physical sciences and the application of these techniques to pharmacologically relevant problems.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008210-17
Application #
6765920
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Preusch, Peter C
Project Start
1988-07-01
Project End
2008-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
17
Fiscal Year
2004
Total Cost
$149,419
Indirect Cost
Name
Cornell University
Department
Other Basic Sciences
Type
Schools of Veterinary Medicine
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Veatch, Sarah L; Chiang, Ethan N; Sengupta, Prabuddha et al. (2012) Quantitative nanoscale analysis of IgE-Fc?RI clustering and coupling to early signaling proteins. J Phys Chem B 116:6923-35
Heger, Christopher D; Wrann, Christiane D; Collins, Ruth N (2011) Phosphorylation provides a negative mode of regulation for the yeast Rab GTPase Sec4p. PLoS One 6:e24332
Binns, Derk; Lee, Sungkyung; Hilton, Christopher L et al. (2010) Seipin is a discrete homooligomer. Biochemistry 49:10747-55
Hammond, Stephanie; Wagenknecht-Wiesner, Alice; Veatch, Sarah L et al. (2009) Roles for SH2 and SH3 domains in Lyn kinase association with activated FcepsilonRI in RBL mast cells revealed by patterned surface analysis. J Struct Biol 168:161-7
Vazquez, R W; Oswald, R E (1999) Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, alpha7. Mol Pharmacol 55:1-7
Wo, Z G; Chohan, K K; Chen, H et al. (1999) Cysteine mutagenesis and homology modeling of the ligand-binding site of a kainate-binding protein. J Biol Chem 274:37210-8
Guo, W; Sutcliffe, M J; Cerione, R A et al. (1998) Identification of the binding surface on Cdc42Hs for p21-activated kinase. Biochemistry 37:14030-7
Feltham, J L; Dotsch, V; Raza, S et al. (1997) Definition of the switch surface in the solution structure of Cdc42Hs. Biochemistry 36:8755-66
Glaven, J A; Whitehead, I P; Nomanbhoy, T et al. (1996) Lfc and Lsc oncoproteins represent two new guanine nucleotide exchange factors for the Rho GTP-binding protein. J Biol Chem 271:27374-81
Wo, Z G; Oswald, R E (1995) Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci 18:161-8

Showing the most recent 10 out of 19 publications